Homozygous familial hypercholesterolemia (HoFH) medications comprise mipomersen and lomitapide. Lomitapide is an FDA-approved in addition to a diet low in fats, and other drugs used to reduce lipids, to decrease low-density lipoprotein (LDL) cholesterol, apolipoprotein B, and other lipoproteins, in patients suffering from HoFH.
Copyright © 2024, StatPearls Publishing LLC.